Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

Part of paid clinical trials in Tampa, Florida.

Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Study ID
NCT07222995
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Precision Prevention Booklet — BEHAVIORAL
    Precision prevention booklet anchored in their MC1R risk that incorporates gold-standard risk communication strategies, including visual risk representations and simple language.
  • Standard Prevention Booklet — BEHAVIORAL
    Standard materials are similar in content to the precision prevention booklet but without any reference to MC1R risk.

Study Details

The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.

Key Dates

Start date
Oct 10, 2025
Status verified
Feb 2026
Primary completion
Oct 10, 2030
Completion
Oct 10, 2030

Study Design

Enrollment
2,900 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: Precision Prevention Intervention
    Participants receive personalized skin cancer prevention materials based on MC1R genetic risk.
  • Active Comparator: Standard Prevention
    Participants receive standard skin cancer prevention materials.
  • No Intervention: Non-Intervention
    Participants who do not return saliva kits will not receive intervention materials but will complete follow-up assessments.

Primary Outcome Measure

Change in Tanning Score [ Time Frame: Baseline, 6 months, 12 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Moffitt Cancer CenterTampaFlorida33612
Peter Kanetsky, PhD, MPH (PRINCIPAL_INVESTIGATOR)
Margaret Byrne, PhD (SUB_INVESTIGATOR)
Susan Vadaparampil, PhD (SUB_INVESTIGATOR)
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065-

Find similar trials in Tampa, FL

By condition
Skin cancer
By specialty
OncologySkin cancerDermatology
By research site
Moffitt Cancer Center· Tampa, FLMemorial Sloan Kettering Cancer Center· New York, NY

Related Studies